Newsroom

JANUARY 12, 2022 This digital health collaboration combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander, to address the challenges with inpatient blood sugar management at the hospital bedside. Glucommander will be the first software application available to run on Roche’s smart-device next-generation...

JANUARY 12, 2022 by SEAN WHOOLEY Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration. Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address the challenges...

JANUARY 12, 2022 by Conor Hale Roche has launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The cobas pulse will start shipping to select countries in Europe, carrying a CE mark, Roche said during the J.P. Morgan Healthcare Conference. The company said it plans to seek...

JANUARY 12, 2022 Amanda Petersen The partnership will leverage Glytec's insulin dosing support software to address challenges with hospital inpatient blood sugar management. Glytec, a Gold winner in the 2021 Medical Design Excellence Awards competition, has nabbed a rather big partnership with Roche that will ultimately benefit countless hospital patients and their clinicians. Through a digital...

Leader in Endocrinology Research Implements eGlycemic Management System Across Hospitals, Dedicates Resources Towards Research and Development WALTHAM, Mass. (January 25, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around...

JANUARY 4, 2021 By: Sean Whooley Glytec announced today that its eGlycemic Management System received certified status for information security from HITRUST. Waltham, Massachusetts-based Glytec’s certification validates its platform’s ability to meet the highest standards for protecting sensitive data and information when working with its health system customers. According to a news release,...

As CMS Creates an Emphasis on Hyperglycemia and Hypoglycemia Rates in the Hospital, Partnership Aims to Transform the Standard of Care WALTHAM, MASS. (January 12, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a strategic partnership with Roche Diagnostics USA, a division of the world’s largest biotech company and a...

HITRUST CSF Certification validates Glytec is committed to meeting key regulations and protecting sensitive information. WALTHAM, MASS. (January 4, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced that Glytec’s eGlycemic Management System®, including Glucommander™, has achieved Certified status for information security by...

AUGUST 22 2021 By Dr. Jordan Messler In 1921, Sir Frederick G. Banting, Charles H. Best and JJR Macleod discovered insulin at the University of Toronto. This innovation changed the course of history for individuals with type 1 diabetes, caregivers and others who require insulin. The 100 years that followed have been revolutionary. Additional outpatient inventions, such as insulin pens,...

JULY 14 2021 Steven Loeb Glytec's electronic glycemic management system uses data to determine patient insulin levels Steven Loeb and Bambi Francisco interview John Downey, Chief Commercial Officer at Glytec, a provider of electronic glycemic management systems (eGMS), using real-time data to ensure that hospitals give patients the right level of insulin. The company's eGMS is called...